Quest for the right Drug
רוקסט פלוס ROKACET PLUS (CAFFEINE ANHYDROUS, CODEINE PHOSPHATE, PARACETAMOL)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
קפליות : CAPLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Interactions : אינטראקציות
4.5 Interaction with other medicinal products and other forms of interaction Paracetamol The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by cholestyramine. Cholestyramine should not be administered within one hour of taking paracetamol. Page 7 of 17 The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of paracetamol with increased risk of bleeding; occasional doses have no significant effect. Paracetamol is metabolised in the liver and can therefore interact with other medicines that follow the same pathway or may inhibit or induce this route (e.g. barbiturates, such as phenobarbitone, tricyclic antidepressants, alcohol, carbamazepine, phenytoin, primidone, rifampicin, St John’s Wwort or other drugs that induce liver enzymes),causing hepatotoxicity, particularly in overdose (see section 4.9). In case of concomitant treatment with probenecid, the dose of paracetamol should be reduced because probenecid reduces the clearance of paracetamol by 50% since it prevents the conjugation of paracetamol with glucuronic acid. There is limited evidence suggesting that paracetamol may affect chloramphenicol pharmacokinetics, but its validity has been criticised and evidence of a clinically relevant interaction appears to be lacking. Although no routine monitoring is needed, it is important to bear in mind this potential interaction when these two medications are concomitantly administered, especially in malnourished patients. Caution should be taken when paracetamol is used concomitantly with flucloxacillin as concurrent intake has been associated with high anion gap metabolic acidosis, especially in patients with risks factors (see section 4.4). Caffeine Caffeine, a CNS stimulant, has an antagonistic effect towards the action of sedatives and tranquilizers. Caffeine may enhance the tachycardia effect of some decongestants. Codeine Codeine may antagonize the effects of metoclopramide and domperidone on gastrointestinal motility. Codeine potentiates the central depressive effects of central nervous system depressants including alcohol, anaesthetics, hypnotics, sedatives, tricyclic antidepressants and phenothiazines. Opioid analgesics should be given with care to patients receiving monoamine oxidase inhibitors. The effect of CNS depressants (including alcohol) may be potentiated by codeine; these interactions are unlikely to be significant at the dosage involved. MAOIs taken with pethidine have been associated with severe CNS excitation or depression (including hypertension or hypotension). Although this has not been documented with codeine, it is possible that a similar interaction may occur and therefore the use of codeine should be avoided while the patient is taking MAOIs and for 2 weeks after MAOI discontinuation. Page 8 of 17 Opiate analgesics may interact with monoamine oxidase inhibitors (MAOI) and result in serotonin syndrome. It is recommended that the product should not be taken concurrently or within two weeks of stopping treatment with a MAOI. Sedative medicines such as benzodiazepines or related drugs: The concomitant use of opioids with sedative medicines such as benzodiazepines or related drugs increases the risk of sedation, respiratory depression, coma and death because of additive CNS depressant effect. The dose and duration of concomitant use should be limited (see section 4.4).
שימוש לפי פנקס קופ''ח כללית 1994
Pain, fever
תאריך הכללה מקורי בסל
01/01/1995
הגבלות
תרופה שאושרה לשימוש כללי בקופ'ח
מידע נוסף
עלון מידע לצרכן
20.07.21 - עלון לצרכן אנגלית 18.04.21 - עלון לצרכן עברית 20.07.21 - עלון לצרכן ערבית 18.09.22 - עלון לצרכן אנגלית 18.09.22 - עלון לצרכן עברית 18.09.22 - עלון לצרכן ערבית 30.08.23 - עלון לצרכן אנגלית 30.08.23 - עלון לצרכן עברית 30.08.23 - עלון לצרכן ערבית 29.11.23 - עלון לצרכן אנגלית 29.11.23 - עלון לצרכן עברית 29.11.23 - עלון לצרכן ערבית 26.01.24 - עלון לצרכן אנגלית 18.04.21 - החמרה לעלון 20.07.21 - החמרה לעלון 12.09.13 - החמרה לעלון 06.06.19 - החמרה לעלון 18.09.22 - החמרה לעלון 30.08.23 - החמרה לעלון 29.11.23 - החמרה לעלוןלתרופה במאגר משרד הבריאות
רוקסט פלוס
